The shared tumor-specific antigen encoded by mouse gene P1A is a target not only for cytolytic T lymphocytes but also for tumor rejection

European Journal of Immunology

Volumn 28, Issue 12, 1998, Pages 4010-4019

  Brändle, Daniel ^a,b,d   Bilsborough, Janine ^a,b   Rülicke, Thomas ^c   Uyttenhove, Catherine ^a,b   Boon, Thierry ^a,b   Van Den Eynde, Benoît J ^a,b  

^a LUDWIG INSTITUTE FOR CANCER RESEARCH   (Belgium)

^b UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^c UNIVERSITY OF ZURICH   (Switzerland)

^d Cilag AG   (Switzerland)

Author keywords

Cytotoxic T lymphocyte; P1A; P815; Rejection; Tumor antigen

Indexed keywords

B7 ANTIGEN; TUMOR ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CANCER IMMUNIZATION; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; GENE; LEUKEMIA L 1210; MASTOCYTOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSGENIC MOUSE; TUMOR REJECTION;

EID: 0031767121     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-4141(199812)28:12<4010::AID-IMMU4010>3.0.CO;2-5     Document Type: Article

References (50)

1. Van den Eynde, B. and van der Bruggen, P., T cell-defined tumor antigens. Curr. Opin. Immunol. 1997. 9: 684-693.
2. Van den Eynde, B., Lethé, B., Van Pel, A., De Plaen, E. and Boon, T., The gene coding for a major tumor rejection antigen of tumor P815 is identical to the normal gene of syngeneic DBA/2 mice. J. Exp. Med. 1991. 173: 1373-1384.
3. Van den Eynde, B., Peeters, O., De Backer, O., Gaugler, B., Lucas, S. and Boon, T., A new family of genes coding for an antigen recognized by autologous cytolytic T lymphocytes on a human melanoma. J. Exp. Med. 1995. 182: 689-698.
4. van der Bruggen, P., Traversari, C., Chomez, P., Lurquin, C., De Plaen, E., Van den Eynde, B., Knuth, A. and Boon, T., A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science 1991. 254: 1643-1647.
5. Gaugler, B., Van den Eynde, B., van der Bruggen, P., Romero, P., Gaforio, J. J., De Plaen, E., Lethé, B., Brasseur, F. and Boon, T., Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes. J. Exp. Med. 1994. 179: 921-930.
6. Traversari, C., van der Bruggen, P., Luescher, I. F., Lurquin, C., Chomez, P., Van Pel, A., De Plaen, E., Amar-Costesec, A. and Boon, T., A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-A1 by cytolytic T lymphocytes directed against tumor antigen MZ2-E. J. Exp. Med. 1992. 176: 1453-1457.
7. Boël, P., Wildmann, C., Sensi, M.-L., Brasseur, R., Renauld, J.-C., Coulie, P., Boon, T. and van der Bruggen, P., BAGE, a new gene encoding an antigen recognized on human melanomas by cytolytic T lymphocytes. Immunity 1995. 2: 167-175.
8. Sahin, U., Türeci, O. and Pfreundschuh, M., Serological identification of human tumor antigens. Curr. Opin. Immunol. 1997. 9: 709-716.
9. Brichard, V., Van Pel, A., Wölfel, T., Wölfel, C., De Plaen, E., Lethé, B., Coulie, P. and Boon, T., The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J. Exp. Med. 1993. 178: 489-495.
10. Coulie, P. G., Brichard, V., Van Pel, A., Wölfel, T., Schneider, J., Traversari, C., Mattei, S., De Plaen, E., Lurquin, C., Szikora, J.-P., Renauld, J.-C. and Boon, T., A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J. Exp. Med. 1994. 180: 35-42.
11. Bakker, A. B. H., Schreurs, M. W. J., de Boer, A. J., Kawakami, Y., Rosenberg, S. A., Adema, G. J. and Figdor, C. G., Melanocyte lineage-specific antigen gp100 is recognized by melanoma-derived tumorinfiltrating lymphocytes. J. Exp. Med. 1994. 179: 1005-1009.
12. Coulie, P. G., Lehmann, F., Lethé, B., Herman, J., Lurquin, C., Andrawiss, M. and Boon, T., A mutated intron sequence codes for an antigenic peptide recognized by cytolytic T lymphocytes on a human melanoma. Proc. Natl. Acad. Sci. USA 1995. 92: 7976-7980.
13. Mandelboim, O., Berke, G., Fridkin, M., Feldman, M., Eisenstein, M. and Eisenbach, L., CTL induction by a tumour-associated antigen octapeptide derived from a murine lung carcinoma. Nature 1994. 369: 67-71.
14. Monach, P. A., Meredith, S. C., Siegel, C. T. and Schreiber, H., A unique tumor antigen produced by a single amino acid substitution. Immunity 1995. 2: 45-59.
15. INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma. Science 1995. 269: 1281-1284.
16. Robbins, P. F., El-Gamil, M., Li, Y. F., Kawakami, Y., Loftus, D., Appella, E. and Rosenberg, S. A., A mutated β-catenin gene encodes a melanoma-specific antigen recognized by tumor infiltrating lymphocytes. J. Exp. Med. 1996. 183: 1185-1192.
17. Dubey, P., Hendrickson, R. C., Meredith, S. C., Siegel, C. T., Shabanowitz, J., Skipper, J. C. A., Engelhard, V. H., Hunt, D. F. and Schreiber, H., The immunodominant antigen of an ultraviolet-induced regressor tumor is generated by a somatic point mutation in the DEAD box helicase p68. J. Exp. Med. 1997. 185: 695-705.
18. Marchand, M., Weynants, P., Rankin, E., Arienti, F., Belli, F., Parmiani, G., Cascinelli, N., Bourlond, A., Vanwijck, R., Humblet, Y., Canon, J.-L., Laurent, C., Naeyaert, J.-M., Plagne, R., Deraemaeker, R., Knuth, A., Jäger, E., Brasseur, F., Herman, J., Coulie, P. G. and Boon, T., Tumor regression responses in melanoma patients treated with a peptide encoded by gene MAGE-3. Int. J. Cancer 1995. 63: 883-885.
19. Mukherji, B., Chakraborty, N. G., Yamasaki, S., Okino, T., Yamase, H., Sporn, J. R., Kurtzman, S. K., Ergin, M. T., Ozols, J., Meehan, J. and Mauri, F., Induction of antigen-specific cytolytic T cells in situ in human melanoma by immunization with synthetic peptide-pulsed autologous antigen presenting cells. Proc. Natl. Acad. Sci. USA 1995. 92: 8078-8082.
20. Nestle, F. O., Alijagic, S., Gilliet, M., Sun, Y, Grabbe, S., Dummer, R., Burg, G. and Schadendorf, D., Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells. Nature Med. 1998. 4: 328-332.
21. Srivastava, P. K., Do human cancers express shared protective antigens? or The necessity of remembrance of things past. Semin, Immunol. 1996. 8: 295-302.
22. Ramarathinam, L., Sarma, S., Maric, M., Zhao, M., Yang, G., Chen, L. and Liu, Y., Multiple lineages of tumors express a common tumor antigen, P1A, but they are not cross-protected. J. Immunol. 1995. 155: 5323-5329.
23. Mumberg, D., Wick, M. and Schreiber, H., Unique tumor antigens redefined as mutant tumor-specific antigens. Semin, Immunol. 1996. 8: 289-293.
24. Gross, L., Intradermal immunization of C3H mice against a sarcoma that originated in an animal of the same line. Cancer Res. 1943. 3: 326-333.
25. Prehn, R. T. and Main, J. M., Immunity to methylcholanthrene-induced sarcomas. J. Natl. Cancer Inst. 1957. 18: 769-778.
26. Klein, G., Sjögren, H., Klein, E. and Hellström, K. E., Demonstration of resistance against methylcholanthrene-induced sarcomas in the primary autochthonous host. Cancer Res. 1960. 20: 1561-1572.
27. Old, L. J., Boyse, E. A., Clarke, D. A. and Carswell, E. A., Antigenic properties of chemically-induced tumors. Ann. N.Y. Acad. Sci. 1962. 10: 80-106.
28. Uyttenhove, C., Godfraind, C., Lethé, B., Amar-Costesec, A., Renauld, J.-C., Gajewski, T. F, Duffour, T., Warnier, G., Boon, T. and Van den Eynde, B. J., The expression of mouse gene P1A in testis does not prevent safe induction of cytolytic T cells against a P1A-encoded tumor antigen. Int. J. Cancer 1997. 70: 349-356.
29. Warnier, G., Duffour, M.-T., Uyttenhove, C., Perricaudet, M., Lurquin, C., Haddada, H. and Boon, T., Induction of a cytolytic T cell response in mice with a recombinant adenovirus coding for tumor antigen P815A. Int. J. Cancer 1996. 67: 303-310.
30. a encoded antigens in T cell receptor Vβ8.1 chain transgenic mice. EMBO J. 1989. 8: 719-727.
31. - transplantation antigen P198: a point mutation generates a new antigenic peptide. J. Exp. Med. 1990. 172: 35-45.
32. Grohmann, U., Bianchi, R., Fioretti, M. C., Fallarino, F., Binaglia, L., Uyttenhove, C., Van Pel, A., Boon, T. and Puccetti, P., CD8+ cell activation to a major mastocytoma rejection antigen. P815AB: requirement for tumor helper peptides in priming for skin test reactivity to a P815AB-related peptide. Eur. J. Immunol. 1995. 25: 2797-2802.
33. Kast, W. M. and Melief, C. J. M., Fine peptide specificity of cytotoxic T lymphocytes directed against adenovirus-induced tumours and peptide-MHC binding. Int. J. Cancer Suppl. 1991. 6: 90-94.
34. Feltkamp, M. C. W., Smits, H. L., Vierboom, M. P. M., Minnaar, R. P., de Jongh, B. M., Drijfhout, J. W., ter Schegget, J., Melief, C. J. M. and Kast, W. M., Vaccination with cytotoxic T lymphocyte epitope-containing peptide protects against a tumor induced by Human Papillomavirus type 16-transformed cells. Bur. J. Immunol. 1993. 23: 2242-2249.
35. Boon, T., Toward a Genetic Analysis of Tumor Rejection Antigens. Adv. Cancer Res. 1992. 58: 177-210.
36. Uyttenhove, C., Maryanski, J. and Boon, T., Escape of mouse mastocytoma P815 after nearly complete rejection is due to antigen-loss variants rather than immunosuppression. J. Exp. Med. 1983. 157: 1040-1052.
37. Rosato, A., Zambon, A., Milan, G., Ciminale, V., D'Agostina, D., Macino, B., Zanovello, P. and Collavo, D., CTL response and protection against tumor challenge in mice immunized with DNA expressing the tumor-specific antigen P815A. Hum. Gene Ther. 1997. 8: 1451-1458.
38. Van den Eynde, B., Hainaut, P., Hérin, M., Knuth, A., Lemoine, C., Weynants, P., van der Bruggen, P., Fauchet, R. and Boon, T., Presence on a human melanoma of multiple antigens recognized by autologous CTL. Int. J. Cancer 1989. 44: 634-640.
39. Degiovanni, G., Lahaye, T., Hérin, M., Hainaut, P. and Boon, T., Antigenic heterogeneity of a human melanoma tumor detected by autologous CTL clones. Eur. J. Immunol. 1988. 18: 671-676.
40. Knuth, A., Wölfel, T., Klehmann, E., Boon, T. and Meyer zum Büschenfelde, K.-H., Cytolytic T-cell clones against an autologous human melanoma: specificity study and definition of three antigens by immunoselection. Proc. Natl. Acad. Sci. USA 1989. 86: 2804-2808.
41. Brichard, V. G., Warnier, G., Van Pel, A., Morlighem, G., Lucas, S. and Boon, T., Individual differences in the orientation of the cytolytic T cell response against mouse tumor P815. Eur. J. Immunol. 1995. 25: 664-671.
42. Levraud, J.-P., Pannetier, C., Langlade-Demoyen, P., Brichard, V. and Kourilsky, P., Recurrent T cell receptor rearrangements in the cytotoxic T lymphocyte response in vivo against the P815 murine tumor. J. Exp. Med. 1996. 183: 439-449.
43. Ramarathinam, L., Castle, M., Wu, Y. and Liu, Y., T cell costimulation by B7/BB1 induces CD8 T cell-dependent tumor rejection: an important role of B7/BB1 in the induction, recruitment, and effector function of antitumor T cells. J. Exp. Med. 1994. 179: 1205-1214.
44. Tamura, Y., Peng, P., Liu, K., Daou, M. and Srivastava, P. K., Immunotherapy of tumors with autologous tumorderived heat shock protein preparations. Science 1997. 278: 117-120.
45. Van Pel, A., De Plaen, E. and Boon, T., Selection of a highly transfectable variant from mouse mastocytoma P815. Som. Cell Genet. 1985. 11: 467-475.
46. Gajewski, T. F., Renauld, J.-C., Van Pel, A. and Boon, T., Costimulation with B7-1, IL-6, and IL-12 is sufficient for primary generation of murine anti-tumor cytolytic T lymphocytes in vitro. J. Immunol. 1995. 154: 5637-5648.
47. Mizushima, S. and Nagata, S., pEF-BOS, a powerful mammalian expression vector. Nucleic Acids Res. 1990. 18: 5322.
48. Atherton, E., Logan, C. J. and Sheppard, R. C., Peptide synthesis. Part 2. Procedures for solid phase synthesis using Nα-fluorenylmethysoxycarbamylaminoacid on polymide supports. Synthesis of substance P and of acyl carrier protein 65-74 decapeptide. J. Chem. Soc. Lond. Perkin Trans. 1981. 1: 538-546.
49. Davis, L. G., Dibner, M. D. and Battey, J. F. (Eds.) Basic Methods in Molecular Biology. Elsevier, New York 1986, pp 130-135.
50. Boon, T., Van Snick, J., Van Pel, A., Uyttenhove, C. and Marchand, M., Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. II. T lymphocyte-mediated cytolysis. J. Exp. Med. 1980. 152: 1184-1193